Retrospective comparison of clinical and angiographic outcomes after primary stenting using sirolimus-eluting and bare-metal stents in nonrandomized consecutive 568 patients with first ST-segment elevated myocardial infarctions

Journal of Cardiology

Volumn 57, Issue 1, 2011, Pages 44-52

  Ishikawa, Tetsuya ^a   Mutoh, Makoto ^a   Nakano, Yosuke ^a   Endo, Akira ^a   Kubota, Takeyuki ^a   Suzuki, Teruhiko ^a   Nakata, Kotaro ^a   Murakami, Akimichi ^a   Miyamoto, Takashi ^a   Sakamoto, Hiroshi ^a   Okada, Hisayuki ^a   Imai, Kamon ^a   Yoshimura, Michihiro ^b  

^a SAITAMA CARDIOVASCULAR AND RESPIRATORY CENTER   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioplasty; Drug eluting stent; Myocardial infarction; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; DRUG ELUTING STENT; FEMALE; HEART DEATH; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 78650560745     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.09.005     Document Type: Article

References (35)

1. ® sirolimus-eluting stent (SES) in acute myocardial infarction patients treated with balloon angioplasty. Presented at American College of Cardiology 2009.
2. Violini R., Musto C., De Felice F., Nazzaro M.S., Cifarelli A., Petitti T., Fiorilli R. Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (Sirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction) Trial. J Am Coll Cardiol 2010, 55:810-814.
3. Atary J.Z., van der Hoeven B.L., Liem S.S., Jukema J.W., van der Bom J.G., Atsma D.E., Bootsma M., Zeppenfeld K., van der Wall E.E., Schalij M.J. Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study). Am J Cardiol 2010, 106:4-12.
4. Brar S.S., Leon M.B., Stone G.W., Mehran R., Moses J.W., Brar S.K., Dangas G. Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 2009, 53:1677-1689.
5. ®) in acute myocardial infarction-a Japanese single center retrospective non-randomized study. Circ J 2006, 70:1091-1092.
6. Gochi T., Umeda H., Yoshida N., Maekawa H., Watanabe K., Okada T., Katoh T., Asai T., Tani T., Yokoya M., Murakami Y., Matsushita T., Shimizu T., Ozaki Y., Hiramitsu S., et al. Promising efficacy of the sirolimus-eluting stent in patients with acute myocardial infarction. J Cardiol 2006, 48:253-261. [in Japanese].
7. Takano T., Ogawa S., Kasanuki H., Kimura K., Goto Y., Sumiyoshi T., Daita H., Tanaka K., Nagao K., Hirayama A., Makuuchi H., Yamaguchi T., Yamashina A., Yoshino H. Guidelines for the management of patients with ST-elevation myocardial infarction (JCS 2008). Circ J 2008, 72(Suppl):1347-1411.
8. de la Torre-Hernandez J.M., Alfonso F., Hernandez F., Elizaga J., Sanmartin M., Pinar E., Lozano I., Vazquez J.M., Botas J., Perez de Prado A., Hernández J.M., Sanchis J., Nodar J.M., Gomez-Jaume A., Larman M., et al. Drug-eluting stent thrombosis. Results from the multicenter Spanish registry ESTROFA. J Am Coll Cardiol 2008, 51:986-990.
9. Mutoh M., Ishikawa T., Hasuda T., Okada H., Endo A., Miyanaga S., Higashitani M., Nakano Y., Kubota T., Nakata K., Nagoshi T., Hayashi M., Sakamoto H., Oota M., Imai K., et al. Predictors of target lesion revascularization and documented stent thrombosis beyond 30 days after sirolimus-eluting stent implantation-retrospective analysis in consecutive 1070 angiographic follow-up lesions. Circ J 2007, 71:1328-1331.
10. Kimura T., Morimoto T., Nakagawa Y., Tamura T., Kadota K., Yasumoto H., Nishikawa H., Hiasa Y., Muramatsu T., Meguro T., Inoue N., Honda H., Hayashi Y., Miyazaki S., Oshima S., et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009, 119:987-995.
11. Ishikawa T., Nakano Y., Endoh A., Kubota T., Suzuki T., Nakata K., Miyamoto T., Murakami M., Sakamoto H., Imai K., Mochizuki S., Yoshimura M., Mutoh M. Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: a retrospective comparison with western mega-studies. J Cardiol 2009, 54:238-244.
12. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., Steg P.G., Morel M.A., Mauri L., Vranckx P., McFadden E., Lansky A., Hamon M., Krucoff M.W., Serruys P.W., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
13. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Ornato J.P., Pearle D.L., Sloan M.A., Smith S.C., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004, 110:e82-292.
14. Ishikawa K, Ueshima H, Ogawa H, Kanamasa K, Saito M, Sasaki J, Tsutsui H, Nakamura Y, Nagao K, Hayashi T, Yamaguchi I. Guidelines for secondary prevention of myocardial infarction (JCS 2006), 2006.
15. Fujii K., Carlier S.G., Mintz G.S., Yang Y.M., Moussa I., Weisz G., Dangas G., Mehran R., Lansky A.J., Kreps E.M., Collins M., Stone G.W., Moses J.W., Leon M.B. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005, 45:995-998.
16. Cheneau E., Satler L.F., Escolar E., Suddath W.O., Kent K.M., Weissman N.J., Waksman R., Pichard A.D. Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure. Catheter Cardiovasc Interv 2005, 65:222-226.
17. Okamura A., Ito H., Iwakura K., Kawano S., Inoue K., Maekawa Y., Ogihara T., Fujii K. Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device. J Am Coll Cardiol 2005, 45:212-215.
18. Grines C.L., Bonow R.O., Casey D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., O'Gara P., Whitlow P., American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, American Dental Association, American College of Physicians Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007, 115:813-818.
19. Sakamoto H., Ishikawa T., Mutoh M., Imai K., Mochizuki S. Angiographic and clinical outcomes after sirolimus-eluting stent implantation to de novo ostial lesion of the right coronary artery: a retrospective study. Circ J 2008, 72:880-885.
20. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999, 100:1872-1878.
21. Hannan E.L., Racz M., Holmes D.R., King S.B., Walford G., Ambrose J.A., Sharma S., Katz S., Clark L.T., Jones R.H. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation 2006, 113:2406-2412.
22. Killip T., Kimball J.T. Treatment of myocardial infarction in a coronary care unit. A two-year experience with 250 patients. Am J Cardiol 1967, 20:457-464.
23. Colombo A., Chieffo A. Drug-eluting stent update 2007. Part III. Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 2007, 116:1424-1432.
24. Budoff M.J., Shaw L.J., Liu S.T., Weinstein S.R., Mosler T.P., Tseng P.H., Flores F.R., Callister T.Q., Raggi P., Berman D.S. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007, 49:1860-1870.
25. Sianos G., Papafaklis M.I., Daemen J., Vaina S., van Mieghem C.A., van Domburg R.T., Michalis L.K., Serruys P.W. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 2007, 50:573-583.
26. Grande P., Nielsen A., Wagner G.S., Christiansen C. Quantitative influence of serum creatine kinase isoenzyme MB estimated infarct size and other prognostic variables on one year mortality after acute myocardial infarction. Br Heart J 1985, 53:9-15.
27. Moreno R., Fernández C., Hernández R., Alfonso F., Angiolillo D.J., Sabaté M., Escaned J., Bañuelos C., Fernández-Ortiz A., Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005, 45:954-959.
28. Antoniucci D., Migliorini A., Parodi G., Valenti R., Rodriguez A., Hempel A., Memisha G., Santoro G.M. Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone. Circulation 2004, 109:1704-1706.
29. Silva J.A., Ramee S.R., White C.J., Collins T.J., Jenkins J.S., Nunez E., Zhang S., Jain S.P. Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome. Am Heart J 1999, 138:446-455.
30. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005, 293:2126-2130.
31. Honda Y., Fitzgerald P.J. Stent thrombosis. An issue revised in a changing world. Circulation 2003, 108:2-5.
32. Roy P., Steinberg D.H., Sushinsky S.J., Okabe T., Pinto Slottow T.L., Kaneshige K., Xue Z., Satler L.F., Kent K.M., Suddath W.O., Pichard A.D., Weissman N.J., Lindsay J., Waksman R. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 2008, 29:1851-1857.
33. Kimura T., Morimoto T., Kozuma K., Honda Y., Kume T., Aizawa T., Mitsudo K., Miyazaki S., Yamaguchi T., Hiyoshi E., Nishimura E., Isshiki T. Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Circulation 2010, 122:52-61. RESTART Investigators.
34. Fujiwara H, Endo M, Okada M, Kanmatsuse K, Kamimura S, Koyanagi H, Suzuki T, Nobuyoshi M, Himi K, Furuse A, Hosoda Y, Mitsudo K, Yamaguchi T, Yamaguchi H, Yoshikawa J. Guidelines for percutaneous coronary intervention of coronary artery disease-elective case (JCS 1998-1999), 2000.
35. Valgimigli M., Percoco G., Malagutti P., Campo G., Ferrari F., Barbieri D., Cicchitelli G., McFadden E.P., Merlini F., Ansani L., Guardigli G., Bettini A., Parrinello G., Boersma E., Ferrari R., et al. Tirofiban and sirolimus eluting stent vs abciximab and bare metal stent for acute myocardial infarction: a randomized trial. JAMA 2005, 293:2109-2117.